Company: BDRX
Filing Date: 2025-09-12
Form Type: 424B3
Source: 0001214659-25-013681
Chunk: 19

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-12
Form: 424B3
Chunk 19
---
,280,798,115 |   |
| Basic and diluted loss per share:                            |     |                                       £(0.0002 | ) |     |                                        £(0.001 | ) |

At a General Meeting
on 11 June 2025, shareholders approved the subdivision and redesignation of the Company’s Issued Ordinary Shares of £0.00005
each into to one Ordinary Share of £0.000001 each and 49 ‘D’ Deferred Shares of £0.000001 each. The ‘D’
Deferred Shares have limited rights and are effectively valueless. The share sub-division and redesignation did not impact the calculation
of the denominator as the number of Issued Ordinary Shares did not change.

The Company has
considered the guidance set out in IAS 33 in calculating the denominator in connection with the issuance of Pre-Funded and Abeyance Shares.
Management have recognised the warrants from the date of grant rather than the date of issue of the corresponding Ordinary Shares when
calculating the denominator.

The Group has made
a loss in the current and previous periods presented, and therefore the options and warrants are anti-dilutive. As a result, diluted earnings
per share is presented on the same basis as basic earnings per share.

| 5. | Share capital and reserves |

| Schedule of detailed information about share capital 
 Authorised, allotted and fully                       
 paid – classified as equity                          |     | As at June 30, 2025 
    unaudited Number |     | As at June 30, 2025 
         unaudited £ |     | As at December  31, 2024 Number |     | As at December 31, 2024 £ |
|:-----------------------------------------------------|:----|--------------------:|:----|--------------------:|:----|--------------------------------:|:----|--------------------------:|
| Ordinary shares of £0.000001 each                    |     |      61,952,308,922 |     |              61,952 |     |                   6,685,918,922 |     |                   334,296 |
| ‘A’ Deferred shares of £1 each                       |     |           1,000,001 |     |           1,000,001 |     |                       1,000,001 |     |                 1,000,001 |
| ‘B’ Deferred shares of £0.001 each                   |     |       4,063